EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer

Kae Okuma iD, Tomomichi Kiyomatsu, Hirotoshi Takiyama, Akane Yoshiba, Koji Inaba iD, Tairo Kashihara iD, Kana Takahashi iD, Madoka Sakuramachi, Ayaka Nagao, Hiroshi Igaki iD

Journal of Radiation Research · 23.09.2025 · 66 (5) · 570-577

DOI: 10.1093/jrr/rraf053 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Radiation Research, online erschienen am 22.08.2025. Verfasst von Kae Okuma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Polyglycolic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recurrent gynecologic malignancies following prior pelvic irradiation, definitive radiation therapy is often precluded by cumulative dose constraints to adjacent organs at risk (OARs), and patients may be left with only highly invasive surgical options such as total pelvic exenteration. While some institutions have explored displacement techniques such as artificial ascites or hyaluronic acid gel injection, these approaches are not widely adopted and frequently fail to ensure consistent and stable separation of OARs. We report the first clinical use of Neskeep®, a bioabsorbable polyglycolic acid (PGA) spacer, in high-dose-rate (HDR) brachytherapy for recurrent cervical cancer after prior pelvic radiation. A woman in her 40s with prior hysterectomy and HDR brachytherapy for cervical intraepithelial neoplasia grade III developed vaginal stump recurrence 4 years later. Laparoscopic placement of the PGA spacer was performed to achieve durable displacement of the small bowel, followed by eight fractions of HDR brachytherapy. Hyaluronic acid gel was also injected during each fraction to displace the bladder and rectum. The spacer maintained position and volume throughout treatment without complications. Dose–volume analysis showed a marked reduction in small bowel D₂cc (mean equivalent dose in 2 Gy fractions (EQD₂): 121.6 cGy) compared to the initial treatment (606.0 cGy), while the spacer itself received a mean D₂cc of 690.3 cGy. MRI confirmed complete response at 2 months, with no adverse events observed at that time point. The PGA spacer enabled safe, curative reirradiation in a case that would otherwise be unsuitable for further radiation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUterine Cervical NeoplasmsNeoplasm Recurrence, LocalPolyglycolic AcidAbsorbable ImplantsFemaleHumansAdultRadiotherapy Dosage

Stichwörter der Autor:innen

PGA spacerbiodegradable spacercervical cancerhigh-dose-rate brachytherapyreirradiationsmall bowel dose reduction

Substanzen

Polyglycolic Acid

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
  • Department of Surgery, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Radiation Oncology, QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8655, Japan.

ORCID-Profile: Kae Okuma, Koji Inaba, Tairo Kashihara, Kana Takahashi, Hiroshi Igaki

Zitieren

APA

Okuma, K., Kiyomatsu, T., Takiyama, H., Yoshiba, A., Inaba, K., Kashihara, T., Takahashi, K., Sakuramachi, M., Nagao, A., & Igaki, H. (2025). Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer. Journal of Radiation Research, 66(5), 570-577. https://doi.org/10.1093/jrr/rraf053

Vancouver

Okuma K, Kiyomatsu T, Takiyama H, Yoshiba A, Inaba K, Kashihara T, et al. Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer. Journal of Radiation Research. 2025;66(5):570-577. doi:10.1093/jrr/rraf053

BibTeX
@article{Okuma2025,
  author = {Okuma, Kae and Kiyomatsu, Tomomichi and Takiyama, Hirotoshi and Yoshiba, Akane and Inaba, Koji and Kashihara, Tairo and Takahashi, Kana and Sakuramachi, Madoka and Nagao, Ayaka and Igaki, Hiroshi},
  title = {Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer},
  journal = {Journal of Radiation Research},
  year = {2025},
  volume = {66},
  number = {5},
  pages = {570--577},
  doi = {10.1093/jrr/rraf053}
}
Kostenlos starten →